Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NOVT
NOVT logo

NOVT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
122.350
Open
122.350
VWAP
120.42
Vol
108.28K
Mkt Cap
4.39B
Low
116.930
Amount
13.04M
EV/EBITDA(TTM)
23.89
Total Shares
35.68M
EV
4.27B
EV/OCF(TTM)
66.62
P/S(TTM)
4.61
Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.
Show More

Events Timeline

(ET)
2026-02-23
16:50:00
Sees Q1 Revenue of $250M-$255M
select
2026-02-23
16:50:00
Novanta Q4 Revenue at $258M, Slightly Below Expectations
select
2026-02-23
16:50:00
Sees 2026 Revenue at $1.03B-$1.05B
select
2025-11-05 (ET)
2025-11-05
16:17:10
Novanta Reveals Plan to Offer 11 Million Tangible Equity Units
select
2025-11-03 (ET)
2025-11-03
17:02:26
Novanta Revises FY25 Adjusted EPS Range to $3.24-$3.30 from $3.22-$3.36
select
2025-11-03
17:01:27
Novanta projects Q4 adjusted EPS between 87c and 93c, below consensus estimate of 94c.
select
2025-11-03
17:00:54
Novanta announces Q3 adjusted EPS of 87 cents, surpassing consensus estimate of 82 cents.
select
2025-09-18 (ET)
2025-09-18
08:05:56
Novanta unveils new authorization for $200M share buyback program
select

News

Fool
8.5
03-04Fool
Harvey Partners Acquires New Position in Novanta
  • New Investment Disclosure: On February 17, 2026, Harvey Partners disclosed a new position by acquiring 304,000 shares of Novanta worth $36.17 million, indicating confidence in the company's future prospects.
  • Asset Allocation Analysis: This acquisition accounts for 3.21% of Harvey Partners' 13F reportable assets, highlighting Novanta's significance within the fund's investment portfolio.
  • Company Financial Status: As of February 17, 2026, Novanta's stock price stood at $145.37, remaining flat over the past year and underperforming the S&P 500's 16% gain, raising concerns about its profitability.
  • Future Outlook: Despite a 3% year-over-year revenue increase to $980.6 million in 2025, net income fell from $64.1 million to $53.8 million, with the CEO stating plans to improve margins and cash flow, making it crucial for investors to monitor these developments.
Fool
5.0
02-26Fool
Novanta CEO Matthijs Glastra Sells 7,500 Shares for $1.09 Million
  • Transaction Overview: Novanta CEO Matthijs Glastra sold 7,500 common shares on February 10, 2026, for approximately $1.09 million, marking the largest single transaction in his 10 sell-only trades since February 2023, reflecting his liquidity management strategy.
  • Ownership Changes: Following the sale, Glastra's direct holdings decreased to 57,367 shares, while his indirect holdings via a trust remained unchanged at 54,382 shares, indicating a stable ownership structure without urgency to liquidate his stakes.
  • Performance Highlights: Novanta reported a 9% year-over-year revenue increase in Q4 2025, reaching $258 million, exceeding expectations and contributing to a 3% annual sales growth to $981 million, with forecasts suggesting sales will surpass $1 billion in 2026, showcasing strong business growth potential.
  • Market Reaction: While Glastra's stock sale did not raise market concerns, the company's price-to-earnings ratio of 91 indicates a high stock price, suggesting current shareholders consider selling, while potential buyers should wait for a price correction before entering the market.
NASDAQ.COM
5.0
02-26NASDAQ.COM
Novanta CEO Sells 7,500 Shares for $1.09 Million
  • Executive Sell-off: Novanta CEO Matthijs Glastra sold 7,500 shares on February 10, 2026, for approximately $1.09 million, representing 6.29% of his total holdings, indicating a strategic sell-off at a high stock price.
  • Stable Holding Structure: Post-transaction, Glastra retains 57,367 shares directly and another 54,382 shares in a trust, suggesting confidence in the company's future and a lack of urgency to liquidate his holdings.
  • Strong Performance: Novanta reported Q4 revenue of $258 million, a 9% year-over-year increase, and forecasts sales exceeding $1 billion in 2026, highlighting robust growth in high-demand medical and industrial sectors.
  • Market Reaction Analysis: While Glastra's sale did not raise market concerns, Novanta's price-to-earnings ratio of 91 indicates a high stock price, suggesting investors should consider waiting for a better entry point before purchasing shares.
seekingalpha
9.5
02-24seekingalpha
Novanta Inc. Reports Record Q4 2025 Revenue and Strong Growth
  • Record Revenue: Novanta Inc. achieved record revenue in Q4 2025 with a reported growth of 9%, including 2% organic growth and 4% sequential growth, reflecting strong performance in the medical technology sector.
  • Surge in Bookings: The company experienced a 25% year-over-year increase in bookings and a 12% sequential rise, with a book-to-bill ratio of 1.11, indicating double-digit bookings growth across all businesses for the first time since 2022.
  • Strategic Investments: CEO emphasized strategic investments in minimally invasive surgery, robotic surgery, AI-driven robotics, digital manufacturing, and precision medicine, aiming to enhance the company's leadership in medical technologies and embedded software.
  • Future Outlook: For 2026, GAAP revenue is projected to be between $1.03 billion and $1.05 billion, representing 4% to 6% organic growth, while adjusted gross margin is expected to expand to 47%, demonstrating the company's confidence in future growth.
seekingalpha
9.5
02-24seekingalpha
Novanta Reports Q4 2025 Earnings with Strong Performance
  • Earnings Beat: Novanta's Q4 2025 non-GAAP EPS of $0.91 exceeded expectations by $0.08, indicating a robust enhancement in the company's profitability.
  • Significant Revenue Growth: The quarter's revenue reached $258.3 million, an 8.5% year-over-year increase, surpassing expectations by $4.98 million, reflecting the company's competitive strength and rising customer demand.
  • Adjusted EBITDA Increase: Adjusted EBITDA rose 17% to $60.7 million compared to $52.1 million last year, demonstrating the company's success in cost control and operational efficiency.
  • Optimistic Future Outlook: The company expects GAAP revenue for FY 2026 to range between $1.03 billion and $1.05 billion, with adjusted EBITDA projected between $245 million and $250 million, showcasing confidence in future growth despite foreign exchange risks.
Newsfilter
9.5
02-23Newsfilter
Novanta Reports 2025 Financials: Revenue Growth and Profit Improvement
  • Q4 Performance: In Q4 2025, Novanta achieved GAAP revenue of $258.3 million, a 9% increase year-over-year, with adjusted diluted EPS rising 20% to $0.91, indicating strong performance in the medical technology sector and likely boosting market confidence.
  • Annual Financial Overview: For the full year 2025, GAAP revenue reached $980.6 million, up 3.3% from the previous year, although organic revenue growth slightly declined by 0.5%, reflecting challenges from intensified market competition despite contributions from acquisitions.
  • Customer Bookings Growth: The company reported a 14% increase in customer bookings for 2025, with new product revenues exceeding expectations, demonstrating effective responses to technological innovation and market demand, which is expected to lay the groundwork for future revenue growth.
  • Future Outlook: Novanta anticipates GAAP revenue for 2026 to range between $1.03 billion and $1.05 billion, with adjusted EBITDA projected at $245 million to $250 million, reflecting confidence in ongoing investments and strategic execution aimed at enhancing long-term shareholder value.

Valuation Metrics

The current forward P/E ratio for Novanta Inc (NOVT.O) is 31.31, compared to its 5-year average forward P/E of 46.68. For a more detailed relative valuation and DCF analysis to assess Novanta Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
46.68
Current PE
31.31
Overvalued PE
54.52
Undervalued PE
38.83

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
28.04
Current EV/EBITDA
18.03
Overvalued EV/EBITDA
33.01
Undervalued EV/EBITDA
23.07

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
5.81
Current PS
3.84
Overvalued PS
6.79
Undervalued PS
4.84

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

which stock should i buy, for quick return
Intellectia · 54 candidates
Market Cap: 1000.00M - 8.00BRelative Vol: >= 1.30Beta: HighRiskEarnings Surprise: EpsBeatWeek Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
AN logo
AN
AutoNation Inc
8.00B
CMPO logo
CMPO
Composecure Inc
7.43B
CAMT logo
CAMT
Camtek Ltd
6.70B
FORM logo
FORM
FormFactor Inc
6.47B
LMND logo
LMND
Lemonade Inc
6.38B
RIG logo
RIG
Transocean Ltd
5.10B
breakout stock
Intellectia · 44 candidates
Price Change Pct: >= $0.00Relative Vol: >= 1.20New High Low: 20_HighBeta: HighRiskMoving Average Relationship: PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
INTC logo
INTC
Intel Corp
258.77B
CCJ logo
CCJ
Cameco Corp
53.26B
CARR logo
CARR
Carrier Global Corp
48.63B
KB logo
KB
KB Financial Group Inc
34.09B
FTAI logo
FTAI
FTAI Aviation Ltd
29.44B
SHG logo
SHG
Shinhan Financial Group Co Ltd
27.59B
Looking for day trader alerts
Intellectia · 48 candidates
Rsi Category: overbought, oversoldPrice Change Pct: >= $4.00Relative Vol: >= 1.30Beta: HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
INTC logo
INTC
Intel Corp
258.77B
CCJ logo
CCJ
Cameco Corp
53.26B
KB logo
KB
KB Financial Group Inc
34.09B
GFS logo
GFS
GlobalFoundries Inc
25.50B

Whales Holding NOVT

P
Portolan Capital Management, LLC
Holding
NOVT
+2.11%
3M Return
C
Conestoga Capital Advisors, LLC
Holding
NOVT
+0.95%
3M Return
D
Delaware Management Company
Holding
NOVT
-0.15%
3M Return
A
Aristotle Capital Boston, LLC
Holding
NOVT
-0.38%
3M Return
O
Osterweis Capital Management, Inc.
Holding
NOVT
-1.32%
3M Return
G
Granite Investment Partners, LLC
Holding
NOVT
-1.84%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Novanta Inc (NOVT) stock price today?

The current price of NOVT is 121.98 USD — it has decreased -0.94

What is Novanta Inc (NOVT)'s business?

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.

What is the price predicton of NOVT Stock?

Wall Street analysts forecast NOVT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NOVT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Novanta Inc (NOVT)'s revenue for the last quarter?

Novanta Inc revenue for the last quarter amounts to 258.35M USD, increased 8.52

What is Novanta Inc (NOVT)'s earnings per share (EPS) for the last quarter?

Novanta Inc. EPS for the last quarter amounts to 0.45 USD, decreased -2.17

How many employees does Novanta Inc (NOVT). have?

Novanta Inc (NOVT) has 3000 emplpoyees as of March 11 2026.

What is Novanta Inc (NOVT) market cap?

Today NOVT has the market capitalization of 4.39B USD.